IMUX
Price
$1.13
Change
+$0.05 (+4.67%)
Updated
Apr 2, 04:15 PM (EDT)
Capitalization
95.93M
36 days until earnings call
IPSC
Price
$0.46
Change
+$0.01 (+2.22%)
Updated
Apr 2, 04:16 PM (EDT)
Capitalization
40.96M
36 days until earnings call
Ad is loading...

IMUX vs IPSC

Header iconIMUX vs IPSC Comparison
Open Charts IMUX vs IPSCBanner chart's image
Immunic
Price$1.13
Change+$0.05 (+4.67%)
Volume$100
Capitalization95.93M
Century Therapeutics
Price$0.46
Change+$0.01 (+2.22%)
Volume$100
Capitalization40.96M
IMUX vs IPSC Comparison Chart
Loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
IMUX vs. IPSC commentary
Apr 02, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is IMUX is a StrongBuy and IPSC is a StrongBuy.

Ad is loading...
COMPARISON
Comparison
Apr 02, 2025
Stock price -- (IMUX: $1.07 vs. IPSC: $0.45)
Brand notoriety: IMUX and IPSC are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: IMUX: 104% vs. IPSC: 126%
Market capitalization -- IMUX: $95.93M vs. IPSC: $40.96M
IMUX [@Biotechnology] is valued at $95.93M. IPSC’s [@Biotechnology] market capitalization is $40.96M. The market cap for tickers in the [@Biotechnology] industry ranges from $302.51B to $0. The average market capitalization across the [@Biotechnology] industry is $2.19B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

IMUX’s FA Score shows that 0 FA rating(s) are green whileIPSC’s FA Score has 0 green FA rating(s).

  • IMUX’s FA Score: 0 green, 5 red.
  • IPSC’s FA Score: 0 green, 5 red.
According to our system of comparison, IMUX is a better buy in the long-term than IPSC.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

IMUX’s TA Score shows that 2 TA indicator(s) are bullish while IPSC’s TA Score has 4 bullish TA indicator(s).

  • IMUX’s TA Score: 2 bullish, 5 bearish.
  • IPSC’s TA Score: 4 bullish, 4 bearish.
According to our system of comparison, IPSC is a better buy in the short-term than IMUX.

Price Growth

IMUX (@Biotechnology) experienced а -14.80% price change this week, while IPSC (@Biotechnology) price change was -22.60% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was -4.95%. For the same industry, the average monthly price growth was -7.12%, and the average quarterly price growth was -11.69%.

Reported Earning Dates

IMUX is expected to report earnings on May 08, 2025.

IPSC is expected to report earnings on May 08, 2025.

Industries' Descriptions

@Biotechnology (-4.95% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
IMUX($95.9M) has a higher market cap than IPSC($41M). IMUX YTD gains are higher at: 6.500 vs. IPSC (-55.267). IMUX has higher annual earnings (EBITDA): -95.68M vs. IPSC (-117.21M). IPSC has more cash in the bank: 198M vs. IMUX (59.1M). IMUX has less debt than IPSC: IMUX (899K) vs IPSC (54.6M). IPSC has higher revenues than IMUX: IPSC (2.68M) vs IMUX (0).
IMUXIPSCIMUX / IPSC
Capitalization95.9M41M234%
EBITDA-95.68M-117.21M82%
Gain YTD6.500-55.267-12%
P/E RatioN/AN/A-
Revenue02.68M-
Total Cash59.1M198M30%
Total Debt899K54.6M2%
FUNDAMENTALS RATINGS
IMUX: Fundamental Ratings
IMUX
OUTLOOK RATING
1..100
14
VALUATION
overvalued / fair valued / undervalued
1..100
39
Fair valued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
100
PRICE GROWTH RATING
1..100
62
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
n/a

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
IMUXIPSC
RSI
ODDS (%)
N/A
Bullish Trend 2 days ago
75%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
90%
Bullish Trend 2 days ago
81%
Momentum
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
MACD
ODDS (%)
Bearish Trend 2 days ago
90%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
90%
Advances
ODDS (%)
Bullish Trend 9 days ago
87%
Bullish Trend 10 days ago
83%
Declines
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
90%
Bullish Trend 2 days ago
67%
Aroon
ODDS (%)
N/A
Bearish Trend 2 days ago
90%
View a ticker or compare two or three
Ad is loading...
IMUX
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
IPSC
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
ETWO2.010.01
+0.50%
E2open Parent Holdings
OXY49.19-0.17
-0.34%
Occidental Petroleum Corp
JOB0.20N/A
-0.99%
GEE Group
GRFS6.96-0.15
-2.11%
Grifols SA
VSTM5.82-0.21
-3.48%
Verastem

IMUX and

Correlation & Price change

A.I.dvisor indicates that over the last year, IMUX has been loosely correlated with IPSC. These tickers have moved in lockstep 40% of the time. This A.I.-generated data suggests there is some statistical probability that if IMUX jumps, then IPSC could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IMUX
1D Price
Change %
IMUX100%
-2.29%
IPSC - IMUX
40%
Loosely correlated
-5.08%
VERV - IMUX
39%
Loosely correlated
-9.52%
NTLA - IMUX
39%
Loosely correlated
-6.40%
CRSP - IMUX
39%
Loosely correlated
-2.62%
LYEL - IMUX
38%
Loosely correlated
-9.98%
More

IPSC and

Correlation & Price change

A.I.dvisor indicates that over the last year, IPSC has been loosely correlated with CRSP. These tickers have moved in lockstep 49% of the time. This A.I.-generated data suggests there is some statistical probability that if IPSC jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To IPSC
1D Price
Change %
IPSC100%
-5.08%
CRSP - IPSC
49%
Loosely correlated
-2.62%
FATE - IPSC
47%
Loosely correlated
-4.18%
NTLA - IPSC
46%
Loosely correlated
-6.40%
NKTX - IPSC
46%
Loosely correlated
+0.27%
CRBU - IPSC
45%
Loosely correlated
-7.89%
More